Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO > PROFIT & LOSS
Profit & Loss      
Medicamen Biotech Ltd.
BSE Code 531146
ISIN Demat INE646B01010
Book Value 189.75
NSE Code MEDICAMEQ
Dividend Yield % 0.28
Market Cap 4762.58
P/E 53.88
EPS 6.52
Face Value 10  
(Rs. in Millions)
Particulars Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :          
Gross Sales1723.90  1378.80  1154.50  1101.47  1173.42  
     Sales1723.90  1378.80  1154.50  1101.47  1173.42  
     Job Work/ Contract Receipts          
     Processing Charges / Service Income          
     Revenue from property development          
     Other Operational Income0.00  0.00  0.00  0.00  0.00  
Less: Excise Duty          
Net Sales1723.90  1378.80  1154.50  1101.47  1173.42  
EXPENDITURE :          
Increase/Decrease in Stock-133.20  -103.00  -33.40  10.41  -15.32  
Raw Material Consumed852.80  629.60  468.50  464.39  611.78  
     Opening Raw Materials180.30  115.80  18.00  82.76  83.91  
     Purchases Raw Materials827.90  694.10  566.40  399.62  610.63  
     Closing Raw Materials155.50  180.30  115.80  17.99  82.76  
     Other Direct Purchases / Brought in cost          
     Other raw material cost0.00  0.00  0.00  0.00  0.00  
Power & Fuel Cost71.20  56.70  58.60  26.83  28.96  
     Electricity & Power71.20  56.70  58.60  26.83  28.96  
     Oil, Fuel & Natural gas0.00  0.00  0.00  0.00  0.00  
     Coals etc0.00  0.00  0.00  0.00  0.00  
     Other power & fuel0.00  0.00  0.00  0.00  0.00  
Employee Cost221.20  185.70  145.00  87.92  92.94  
     Salaries, Wages & Bonus205.40  170.50  116.40  69.75  76.48  
     Contributions to EPF & Pension Funds12.60  11.40  8.40  5.82  5.98  
     Workmen and Staff Welfare Expenses3.20  3.80  20.20  12.34  10.49  
     Other Employees Cost0.00  0.00  0.00  0.00  0.00  
Other Manufacturing Expenses293.20  271.10  181.20  264.80  220.01  
     Sub-contracted / Out sourced services          
     Processing Charges45.00  39.70  40.20  33.73  40.00  
     Repairs and Maintenance15.00  13.30  18.50  16.30  15.50  
     Packing Material Consumed194.20  188.40  88.40  193.97  133.14  
     Other Mfg Exp39.00  29.70  34.10  20.80  31.38  
General and Administration Expenses69.00  51.90  49.20  26.27  36.11  
     Rent , Rates & Taxes4.70  4.00  3.70  2.85  3.91  
     Insurance3.30  1.30  1.20  1.18  1.37  
     Printing and stationery18.20  7.50  4.70  3.44  4.07  
     Professional and legal fees15.30  8.30  19.80  7.82  10.47  
     Traveling and conveyance8.80  7.20  3.80  1.44  3.34  
     Other Administration27.50  30.70  19.80  10.98  16.30  
Selling and Distribution Expenses64.80  29.20  33.60  17.13  14.51  
     Handling and Clearing Charges0.00  0.00  0.00  0.00  0.00  
     Other Selling Expenses0.50  1.00  0.30  1.85  1.59  
Miscellaneous Expenses12.50  11.60  10.70  3.44  3.18  
     Bad debts /advances written off          
     Provision for doubtful debts          
     Losson disposal of fixed assets(net)  0.10  0.00  0.01  0.61  
     Losson foreign exchange fluctuations          
     Losson sale of non-trade current investments          
     Other Miscellaneous Expenses12.50  11.50  10.70  3.43  2.57  
Less: Expenses Capitalised          
Total Expenditure1451.50  1132.70  913.50  901.18  992.17  
Operating Profit (Excl OI)272.40  246.20  241.00  200.28  181.25  
Other Income23.10  24.60  17.20  7.54  19.09  
     Interest Received7.10  7.20  1.40  1.53  3.20  
     Dividend Received          
     Profit on sale of Fixed Assets0.00          
     Profits on sale of Investments    0.00  0.04    
     Provision Written Back          
     Foreign Exchange Gains13.70  14.80  14.50  4.71  13.66  
     Others2.20  2.70  1.30  1.26  2.23  
Operating Profit295.40  270.80  258.20  207.82  200.34  
Interest56.50  33.90  19.40  15.12  9.31  
     InterestonDebenture / Bonds          
     Interest on Term Loan          
     Intereston Fixed deposits          
     Bank Charges etc12.70  4.70  5.40  4.48  3.63  
     Other Interest43.80  29.20  14.00  10.64  5.69  
PBDT239.00  236.90  238.80  192.71  191.03  
Depreciation70.10  63.50  57.70  25.20  24.99  
Profit Before Taxation & Exceptional Items168.90  173.30  181.00  167.51  166.04  
Exceptional Income / Expenses          
Profit Before Tax168.90  173.30  181.00  167.51  166.04  
Provision for Tax35.90  23.30  32.00  42.65  43.45  
     Current Income Tax42.20  37.00  39.80  41.45  45.95  
     Deferred Tax-6.30  -13.70  -7.80  1.19  -2.50  
     Other taxes0.00  0.00  0.00  0.00  0.00  
Profit After Tax133.00  150.00  149.10  124.87  122.59  
Extra items0.00  0.00  0.00  0.00  0.00  
Minority Interest          
Share of Associate          
Other Consolidated Items          
Consolidated Net Profit133.00  150.00  149.10  124.87  122.59  
Adjustments to PAT          
Profit Balance B/F821.50  683.20  544.30  425.56  317.68  
Appropriations954.40  833.20  693.40  550.43  440.27  
     General Reserves          
     Proposed Equity Dividend          
     Corporate dividend tax          
     Other Appropriation12.70  11.80  12.20  6.11  14.70  
Equity Dividend %10.00  10.00  10.00  10.00  5.00  
Earnings Per Share10.00  12.00  12.00  10.00  10.00  
Adjusted EPS10.00  12.00  12.00  10.00  10.00  
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.